Fidelity Investments’s Seaport Therapeutics SPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$37.1M Buy
1,837,672
+652,572
+55% +$14.5M ﹤0.01% 1630
2026
Q2
$25.7M Buy
+1,185,100
New +$20.8M ﹤0.01% 1785

Other funds holding SPTX

Fidelity Investments's SPTX Position: Q3 2026 in Review

Fidelity Investments increased its Seaport Therapeutics (SPTX) stake by 55% in Q3 2026, buying an estimated $14.5M and bringing the position to 1,837,672 shares worth $37.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1630.

Fidelity Investments first reported a position in SPTX in Q2 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold SPTX as of Q3 2026.

  • Fidelity Investments held 1,837,672 shares of Seaport Therapeutics worth $37.1M as of Q3 2026.
  • Fidelity Investments bought 652,572 Seaport Therapeutics shares in Q3 2026, an estimated $14.5M.
  • Seaport Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #1630 holding.
  • Fidelity Investments first reported a position in Seaport Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 74 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.